Key Players
- 89bio
- Adocia
- Afimmune Pharmaceutical
- Amryt Pharma
- Arrowhead Pharmaceuticals
- BlackRock
- Ionis Pharmaceuticals
- NorthSea Therapeutics B.V
- Novo Nordisk A/S
- The Vanguard Group
- Regeneron Pharmaceuticals
- L'Oréal
- Zucara Therapeutics
Severe Hypertriglyceridemia (SHTG) Treatment Market
Starting at US$ 5000
Buy Now
